LONDON, UK, 4 March 2025 - In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumours (NETs), a ...
Alpha Tau Medical’s proprietary Alpha DaRT device safely delivers alpha radiation with localized precision to treat cancers. Alpha Tau is waiting for FDA feedback to initiate a US pivotal trial in ...
MANHATTAN, Kan. — Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and effective storage lockers for harmful isotopes that emit ionizing radiation ...
Perspective Therapeutics' pipeline, led by VMT-a-NET, shows promising safety and early efficacy, but lacks clear superiority over existing therapies like Lutathera so far. The company maintains a ...
Alpha DaRT technology uses diffusing alpha emitters to treat solid tumours. (Courtesy: Alpha Tau Medical) Diffusing alpha-emitters radiation therapy (DaRT) uses interstitial radioactive seeds that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback